Overview

Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study

Status:
Enrolling by invitation
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
An open label, prospective, single center, pilot trial to assess feasibility and tolerability of short term blood pressure augmentation to minimize infarct progression in acute LVO stroke patients undergoing endovascular therapy.
Phase:
Early Phase 1
Details
Lead Sponsor:
Yale University
Treatments:
Norepinephrine
Oxymetazoline
Phenylephrine
Synephrine